Cirrhosis epidemiology and demographics: Difference between revisions
Line 12: | Line 12: | ||
Little is known on modulators of cirrhosis risk. Studies have recently suggested that coffee consumption may protect against cirrhosis, especially alcoholic cirrhosis.<ref name=Klatsky>Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. ''Arch Intern Med'' 2006;166:1190-5. PMID 16772246.</ref> Alcoholic cirrhosis develops in 15% of individuals who drink heavily for more than a decade. There is great variability in the amount of alcohol needed to cause cirrhosis (as little as 3-4 drinks a day in some men and 2-3 in some women). | Little is known on modulators of cirrhosis risk. Studies have recently suggested that coffee consumption may protect against cirrhosis, especially alcoholic cirrhosis.<ref name=Klatsky>Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. ''Arch Intern Med'' 2006;166:1190-5. PMID 16772246.</ref> Alcoholic cirrhosis develops in 15% of individuals who drink heavily for more than a decade. There is great variability in the amount of alcohol needed to cause cirrhosis (as little as 3-4 drinks a day in some men and 2-3 in some women). | ||
* ''Chronic [[hepatitis B]]''. The [[hepatitis B virus]] is probably the most common cause of cirrhosis worldwide, especially South-East Asia, but it is less common in the United States and the Western world. | * ''Chronic [[hepatitis B]]''. The [[hepatitis B virus]] is probably the most common cause of cirrhosis worldwide, especially South-East Asia, but it is less common in the United States and the Western world. | ||
* ''[[Primary biliary cirrhosis]]'' : It is more common in women. | |||
==References== | ==References== |
Revision as of 08:54, 29 July 2012
Cirrhosis Microchapters |
Diagnosis |
---|
Treatment |
Case studies |
Cirrhosis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Cirrhosis epidemiology and demographics |
Risk calculators and risk factors for Cirrhosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Overview
Epidemiology and Demographics
Cirrhosis and chronic liver disease were the 10th leading cause of death for men and the 12th for women in the United States in 2001, killing about 27,000 people each year.[1] Also, the cost of cirrhosis in terms of human suffering, hospital costs, and lost productivity is high.
Established cirrhosis has a 10-year mortality of 34-66%, largely dependent on the cause of the cirrhosis; alcoholic cirrhosis has a worse prognosis than primary biliary cirrhosis and cirrhosis due to hepatitis. The risk of death due to all causes is increased twelvefold; if one excludes the direct consequences of the liver disease, there is still a fivefold increased risk of death in all disease categories.[2]
Little is known on modulators of cirrhosis risk. Studies have recently suggested that coffee consumption may protect against cirrhosis, especially alcoholic cirrhosis.[3] Alcoholic cirrhosis develops in 15% of individuals who drink heavily for more than a decade. There is great variability in the amount of alcohol needed to cause cirrhosis (as little as 3-4 drinks a day in some men and 2-3 in some women).
- Chronic hepatitis B. The hepatitis B virus is probably the most common cause of cirrhosis worldwide, especially South-East Asia, but it is less common in the United States and the Western world.
- Primary biliary cirrhosis : It is more common in women.
References
- ↑ Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep2003;52:1-85. PMID 14626726.
- ↑ Sorensen HT, Thulstrup AM, Mellemkjar L, Jepsen P, Christensen E, Olsen JH, Vilstrup H. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol2003;56:88-93. PMID 12589875.
- ↑ Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006;166:1190-5. PMID 16772246.